Astria Therapeutics, Inc. (ATXS)
NASDAQ: ATXS · Real-Time Price · USD
12.93
-0.19 (-1.45%)
Dec 5, 2025, 4:00 PM EST - Market closed
Astria Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Cash & Equivalents | 96.28 | 59.82 | 175.53 | 20.53 | 86.51 | 24.93 | Upgrade
|
| Short-Term Investments | 131.44 | 268.31 | 71 | 205.91 | 39 | 20 | Upgrade
|
| Cash & Short-Term Investments | 227.72 | 328.13 | 246.53 | 226.44 | 125.51 | 44.93 | Upgrade
|
| Cash Growth | -33.86% | 33.10% | 8.87% | 80.42% | 179.34% | 23.96% | Upgrade
|
| Prepaid Expenses | 8.58 | 6.51 | 4.41 | 1.25 | 1.45 | 1.4 | Upgrade
|
| Restricted Cash | - | - | - | - | 0.12 | - | Upgrade
|
| Total Current Assets | 253.55 | 334.64 | 250.94 | 227.69 | 127.08 | 46.33 | Upgrade
|
| Property, Plant & Equipment | 4.25 | 5.11 | 0.36 | 0.95 | 0.39 | 0.97 | Upgrade
|
| Other Long-Term Assets | 14.07 | 2.61 | 3.36 | 2 | 0.05 | 0.17 | Upgrade
|
| Total Assets | 271.87 | 342.36 | 254.67 | 230.63 | 127.51 | 47.46 | Upgrade
|
| Accounts Payable | 1.14 | 4.32 | 1.51 | 0.79 | 1.56 | 1.54 | Upgrade
|
| Accrued Expenses | 16.48 | 13.43 | 9.71 | 7.69 | 3.28 | 4.2 | Upgrade
|
| Current Portion of Leases | 1.4 | 1.38 | 0.33 | 0.58 | 0.37 | 0.65 | Upgrade
|
| Total Current Liabilities | 23.52 | 19.13 | 11.55 | 9.06 | 5.2 | 6.39 | Upgrade
|
| Long-Term Leases | 3.06 | 3.97 | - | 0.36 | - | 0.4 | Upgrade
|
| Other Long-Term Liabilities | 12.04 | - | - | - | - | - | Upgrade
|
| Total Liabilities | 38.61 | 23.1 | 11.55 | 9.42 | 5.2 | 6.79 | Upgrade
|
| Common Stock | 0.06 | 0.06 | 0.04 | 0.03 | 0.01 | 0 | Upgrade
|
| Additional Paid-In Capital | 911.01 | 898.51 | 728.29 | 632.51 | 481.71 | 301.56 | Upgrade
|
| Retained Earnings | -773.2 | -674.79 | -580.53 | -507.64 | -455.81 | -260.9 | Upgrade
|
| Comprehensive Income & Other | 0.06 | 0.16 | - | -0.08 | - | - | Upgrade
|
| Total Common Equity | 137.93 | 223.94 | 147.79 | 124.82 | 25.91 | 40.67 | Upgrade
|
| Shareholders' Equity | 233.25 | 319.26 | 243.12 | 221.22 | 122.31 | 40.67 | Upgrade
|
| Total Liabilities & Equity | 271.87 | 342.36 | 254.67 | 230.63 | 127.51 | 47.46 | Upgrade
|
| Total Debt | 4.46 | 5.35 | 0.33 | 0.94 | 0.37 | 1.05 | Upgrade
|
| Net Cash (Debt) | 223.26 | 322.78 | 246.2 | 225.5 | 125.14 | 43.88 | Upgrade
|
| Net Cash Growth | -34.07% | 31.10% | 9.18% | 80.19% | 185.17% | 29.10% | Upgrade
|
| Net Cash Per Share | 3.85 | 5.75 | 8.17 | 15.42 | 14.02 | 14.35 | Upgrade
|
| Filing Date Shares Outstanding | 57.08 | 56.43 | 54.9 | 27.99 | 13.02 | 3.9 | Upgrade
|
| Total Common Shares Outstanding | 56.43 | 56.43 | 41.03 | 27.5 | 13.02 | 3.35 | Upgrade
|
| Working Capital | 230.03 | 315.51 | 239.39 | 218.63 | 121.87 | 39.94 | Upgrade
|
| Book Value Per Share | 2.44 | 3.97 | 3.60 | 4.54 | 1.99 | 12.15 | Upgrade
|
| Tangible Book Value | 137.93 | 223.94 | 147.79 | 124.82 | 25.91 | 40.67 | Upgrade
|
| Tangible Book Value Per Share | 2.44 | 3.97 | 3.60 | 4.54 | 1.99 | 12.15 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.